Bank of New York Mellon’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bank of New York Mellon's LLY Position: Q2 2026 in Review
Bank of New York Mellon reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $78.6M and leaving 4,783,459 shares worth $5.74B. The position accounts for 0.94% of the portfolio, ranked #14.
Bank of New York Mellon first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.96B in Q2 2024. 3,788 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bank of New York Mellon held 4,783,459 shares of Eli Lilly worth $5.74B as of Q2 2026.
- Bank of New York Mellon sold 76,949 Eli Lilly shares in Q2 2026, an estimated $78.6M.
- Eli Lilly made up 0.94% of Bank of New York Mellon's portfolio in Q2 2026, its #14 holding.
- Bank of New York Mellon first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Eli Lilly position peaked at $5.96B in Q2 2024.
- 3,788 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.